KGK Synergize Receives Multi-Site ISO 9001:2000 Certification
KGK Synergize Inc. (KGK) today announced the achievement of registration of its quality management system, ISO 9001:2000 (#CA05/3474), an international standard published by the International Organization for Standardization (ISO).
London, Ont. -- June 1, 2005 - KGK Synergize Inc. (KGK) today announced the achievement of registration of its quality management system, ISO 9001:2000 (#CA05/3474), an international standard published by the International Organization for Standardization (ISO). The accredited registrar, SGS Systems & Services Certification Canada Inc., confirmed KGK's compliance through a formal audit process. The scope of registration is as follows: "The provision of laboratory testing, analytical services, pre-clinical trials and the establishment of protocols and methods for food products, nature, and the nutraceutical and pharmaceutical product industries in accordance with standard good laboratory practices".
"This important accreditation indicates the on-going dedication of our employees to continuously measure and improve the various processes at KGK, in an effort to present our clients with the best possible customer service available at a research organization", states Robert A. Guthrie, V.P., Contract Research Services Division. "KGK is dedicated to reacting to the needs of our consumers and ISO will enable us to monitor, track and record those needs accordingly".
KGK Synergize provides contract research services in the areas of nutraceutical research, analytical chemistry, immunology, toxicology, autoimmune diseases, etc. and clinical trials.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
